Company intelligence / Profile preview

Nicoya

Kitchener, Ontario, Canadanicoyalife.com ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Nicoya’s benchtop SPR instruments and digital microfluidic platforms are widely adopted by scientists in over 50 countries to accelerate label-free biomolecular analysis. Their technologies enable real-time binding kinetics and affinity data collection for drug discovery, diagnostics, and basic research. No clinical results as they do not develop drugs.

Therapeutic areas: Other
Modalities: Device (Surface Plasmon Resonance systems)Digital microfluidics platform (not a therapeutic company; provides research tools)
Industry: Non-Drug Biotech

Partnerships

Collaborates with academic institutions and researchers globally; specific major pharma/biotech partnerships not listed in public sources.

Beyond the preview

Go deeper on Nicoya.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicoya.

Explore the full profile